Cognizin


Leave less behind.

If you counted every second that has passed since the end of the last ice age, that's equivalent to the number of neurons in your brain.


Download Fact Sheets
For Consumers
For Professionals

Cognizin® Study References

Agut J. Lopez G-Coviella I. Ortiz JA. & Wurtman RJ.: Oral cytidine 5'-diphosphate choline administration to rats increases brain phospholipid levels. Annals of the New York Academy of Sciences. 695:318-20, 1993

Alvarez XA. Sampedro C. Lozano R. & Cacabelos R.: Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats. Methods & Findings in Experimental & Clinical Pharmacology. 21(8):535-40, 1999

Alvarez XA. Mouzo R. Pichel V. Perez P. Laredo M. Fernandez-Novoa L. Corzo L. Zas R. Alcaraz M. Secades JJ. Lozano R. & Cacabelos R.: Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Methods & Findings in Experimental & Clinical Pharmacology. 21(9):633-44, 1999

Alvarez XA. Laredo M. Corzo D. Fernandez-Novoa L. Mouzo R. Perea JE. Daniele D. & Cacabelos R.: Citicoline improves memory performance in elderly subjects. Methods & Findings in Experimental & Clinical Pharmacology. 19(3):201-10, 1997

Andersen M. Overgaard K. Meden P. Boysen G. & Choi SC.: Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke. 30(7):1464-71, 1999

Babb SM., Appelmans KE., Renshaw PF, Wurtman RJ, Cohen BM.: Differential effect of CDP-choline on brain cytosolic choline levels in younger and older subjects as measured by proton magnetic resonance spectroscopy. Psychopharmacology. 127:88-94, 1996.

Babb SM. Wald LL. Cohen BM. Villafuerte RA. Gruber SA. Yurgelun-Todd DA. Renshaw PF.: Chronic Citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology. 161(3):248-54, 2002 May.

Baskaya MK. Dogan A. Rao AM. & Dempsey RJ.: Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury. Journal of Neurosurgery. 92(3):448-52, 2000

Bierer LM. Haroutunian V. Gabriel S. Knott PJ. Carlin LS. Purohit DP. Perl DP. Schmeidler J. Kanof P. & Davis KL.: Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. Journal of Neurochemistry. 64(2):749-60, 1995

Bruhwyler J. Liegeois JF. & Geczy J.: Facilitatory effects of chronically administered citicoline on learning and memory processes in the dog. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 22(1):115-28, 1998

Caamano J. Gomez MJ. Franco A. & Cacabelos R.: Effects of CDP-choline on cognition and cerebral hemodynamics in patients with Alzheimer's disease. Methods & Findings in Experimental & Clinical Pharmacology. 16(3):211-8, 1994

Cacabelos R. Caamano J. Gomez MJ. Fernandez-Novoa L. Franco-Maside A. & Alvarez XA.: Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors. Annals of the New York Academy of Sciences. 777:399-403, 1996

Cacabelos R. Alvarez XA. Franco-Maside A. Fernandez-Novoa L. & Caamano J.: Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Annals of the New York Academy of Sciences. 695:321-3, 1993

Clark W. Gunion-Rinker L. Lessov N. & Hazel K.: Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke. 29(10):2136-40, 1998

Clark WM. Williams BJ. Selzer KA. Zweifler RM. Sabounjian LA. & Gammans RE.: A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 30(12):2592-7, 1999

de la Morena E.: Efficacy of CDP-choline in the treatment of senile alterations in memory. Annals of the New York Academy of Sciences. 640:233-6, 1991

Fernandez-Novoa L. Alvarez XA. Franco-Maside A. Caamano J. & Cacabelos R.: CDP-choline-induced blood histamine changes in Alzheimer's disease. Methods & Findings in Experimental & Clinical Pharmacology. 16(4):279-84, 1994

Fioravanti M. & Yanagi M.: Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database of Systematic Reviews. (4):CD000269, 2000.

Franco-Maside A. Caamano J. Gomez MJ. & Cacabelos R.: Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease. Methods & Findings in Experimental & Clinical Pharmacology. 16(8):597-607, 1994

Fresta M. & Puglisi G.: Reduction of maturation phenomenon in cerebral ischemia with CDP-choline-loaded liposomes. Pharmaceutical Research. 16(12):1843-9, 1999

Fresta M. & Puglisi G.: Survival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-5I-diphosphate choline. Life Sciences. 61(13):1227-35, 1997

Fresta M. Puglisi G. Di Giacomo C. & Russo A.: Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion. Journal of Pharmacy & Pharmacology. 46(12):974-81, 1994

Fujio T. & Maruyama A.: Enzymatic production of pyrimidine nucleotides using Corynebacterium ammoniagenes cells and recombinant Escherichia coli cells: enzymatic production of CDP-choline from orotic acid and choline chloride (Part I). Bioscience, Biotechnology & Biochemistry. 61(6):956-9, 1997

Fujio T. Teshiba S. & Maruyama A.: Construction of a plasmid carrying both CTP synthetase and a fused gene formed from cholinephosphate cytidylyltransferase and choline kinase genes and its application to industrial CDP-choline production: enzymatic production of CDP-choline from orotic acid (Part II). Bioscience, Biotechnology & Biochemistry. 61(6):960-4, 1997

G-Coviella IL. & Wurtman RJ.: Enhancement by cytidine of membrane phospholipid synthesis. Journal of Neurochemistry. 59(1):338-43, 1992

Gimenez R. & Aguilar J.: Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. Neuroscience Letters. 299(3):209-12, 2001

Gimenez R. Soler S. & Aguilar J.: Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats. Neuroscience Letters. 273(3):163-6, 1999

Gimenez R. & Aguilar J.: Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats. European Journal of Pharmacology. 344(2-3):149-52, 1998

Kakihana M. Fukuda N. Suno M. & Nagaoka A.: Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke. 19(2):217-22, 1988

Lopez-Coviella I. Agut J. Savci V. Ortiz JA. & Wurtman RJ.: Evidence that 5'-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels. Journal of Neurochemistry. 65(2):889-94, 1995

Onal MZ. Li F. Tatlisumak T. Locke KW. Sandage BW Jr. & Fisher M.: Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke. 28(5):1060-5, 1997

Parisi V. Manni G. Colacino G. & Bucci MG.: Cytidine-5'-diphosphocholine (citicoline) improves retinal and cortical responses in patients with glaucoma. Ophthalmology. 106(6):1126-34, 1999

Petkov VD. Mosharrof AH. Kehayov R. Petkov VV. Konstantinova E. & Getova D.: Effect of CDP-choline on learning and memory processes in rodents. Methods & Findings in Experimental & Clinical Pharmacology. 14(8):593-605, 1992

Porciatti V. Schiavi C. Benedetti P. Baldi A. & Campos EC.: Cytidine-5'-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects. Current Eye 7) Rao AM. Hatcher JF. & Dempsey RJ.: CDP-choline: neuroprotection in transient forebrain ischemia of gerbils. Journal of Neuroscience Research. 58(5):697-705, 1999

Porciatti V. Schiavi C. Benedetti P. Baldi A. & Campos EC.: Cytidine-5'-diphosphocholine improves visual acuity, contrast sensitivity and visually-evoked potentials of amblyopic subjects. Current Eye Research. 17(2):141-8, 1998

Rao AM. Hatcher JF. & Dempsey RJ.: Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection. Journal of Neurochemistry. 75(6):2528-35, 2000

Schabitz WR. Li F. Irie K. Sandage BW Jr. Locke KW. & Fisher M.: Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke. 30(2):427-32, 1999

Schabitz WR. Weber J. Takano K. Sandage BW. Locke KW. & Fisher M.: The effects of prolonged treatment with citicoline in temporary experimental focal ischemia. Journal of the Neurological Sciences. 138(1-2):21-5, 1996

Secades JJ. & Frontera G.: CDP-choline: pharmacological and clinical review. Methods & Findings in Experimental & Clinical Pharmacology. 17(Suppl B):1-54, 1995

Serra I. Alberghina M. Viola M. Mistretta A. & Giuffrida AM.: Effect of CDP-choline on the biosynthesis of nucleic acids and proteins in brain regions during hypoxia. Neurochemical Research. 6(6):607-18, 1981

Shuaib A. Yang Y. & Li Q.: Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase. Experimental Neurology. 161(2):733-9, 2000

Spiers PA. Myers D. Hochanadel GS. Lieberman HR. Wurtman RJ.: Citicoline improves verbal memory in aging.[erratum appears in Arch Neurol 1996 Oct;53(10):964]. Archives of Neurology. 53(5):441-8, 1996 May.

Trovarelli G. de Medio GE. Dorman RV. Piccinin GL. Horrocks LA. & Porcellati G.: Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochemical Research. 6(8):821-33, 1981

Trovarelli G. Palmerini CA. Floridi A. Piccinin GL. & Porcellati G.: The transport of cytidine into rat brain in vivo, and its conversion into cytidine metabolites. Neurochemical Research. 7(10):1199-207, 1982

Trovarelli G. Palmerini CA. Floridi A. Piccinin GL. & Porcellati G.: The influence of cytidine on the endogenous pool of CDP-choline, CDP-ethanolamine, and CMP of the rat brain. Neurochemical Research. 9(1):73-9, 1984

Vecchini A. Binaglia L. Floridi A. Palmerini CA. & Procellati G.: Uptake and utilization of CDP-choline in primary brain cell cultures from fetal brain. Neurochemical Research. 8(3):333-40, 1983

Wang CS. & Lee RK.: Choline plus cytidine stimulate phospholipid production, and the expression and secretion of amyloid precursor protein in rat PC12 cells. Neuroscience Letters. 283(1):25-8, 2000

Warach S. Pettigrew LC. Dashe JF. Pullicino P. Lefkowitz DM. Sabounjian L. Harnett K. Schwiderski U. & Gammans R.: Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Annals of Neurology. 48(5):713-22, 2000

Wurtman RJ. Regan M. Ulus I. & Yu L.: Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochemical Pharmacology. 60(7):989-92, 2000


These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent
any disease. Cognizin is a trademark of Kyowa Hakko Kogyo Co., Ltd. All rights reserved.
Copyright © 2008 Kyowa Hakko USA. All rights reserved. Privacy Policy